Study Title
Study Details
Description:
Locoregional, intracavitary radioimmunotherapy (iRIT) with a newly developed radioimmunoconjugate (Lu-177 labeled 6A10-Fab-fragments) will be used to prevent or postpone tumour recurrence in patients with GBM following standard therapy .
Sponsor:
University Hospital MuensterGovernment Study Link:
NCT05533242 - Click here to see study onClinicalTrials.gov